Anavex Life Sciences
AVXL
#9707
Rank
C$0.14 B
Marketcap
C$1.59
Share price
-4.20%
Change (1 day)
-85.30%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2026 (TTM): -C$17.68 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$55.95 Million, an increase over its 2024 earnings that were of -C$72.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$17.68 Million-68.4%
2025 -C$55.95 Million-22.43%
2024 -C$72.13 Million14.77%
2023 -C$62.85 Million-17.49%
2022 -C$76.17 Million22.96%
2021 -C$61.94 Million35.36%
2020 -C$45.76 Million12.65%
2019 -C$40.62 Million29.09%
2018 -C$31.47 Million36.33%
2017 -C$23.09 Million17.11%
2016 -C$19.71 Million20.91%
2015 -C$16.3 Million-6.29%
2014 -C$17.4 Million337.28%
2013 -C$3.98 Million
2008 -C$7.36 Million106.01%
2007 -C$3.58 Million8848.98%
2006 -C$0.04 Million-79.99%
2005 -C$0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
C$0.34 B-1,984.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$8.96 M-149.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$8.74 Million-51.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$0.54 Billion 2,842.85%๐Ÿ‡บ๐Ÿ‡ธ USA